Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: I still have a problem with the PDS board:
I think it's actually possible, however, I believe there would be a very serious shareholder law suit filed - especially if TPL completed a buy out at these lows. Shareholders could argue that the SP was intentionally held down since there was no marketing program and minimal information disseminated to the public - among other things.
Share
New Message
Please login to post a reply